| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
8,386 |
8,042 |
$618K |
| J9035 |
Injection, bevacizumab, 10 mg |
5,328 |
5,082 |
$371K |
| J0178 |
Injection, aflibercept, 1 mg |
310 |
307 |
$344K |
| 92134 |
|
12,553 |
12,201 |
$302K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
301 |
296 |
$202K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,554 |
2,541 |
$172K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
296 |
292 |
$148K |
| 92250 |
|
3,967 |
3,913 |
$103K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,304 |
1,290 |
$93K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
827 |
823 |
$86K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
544 |
525 |
$31K |
| 92235 |
|
316 |
316 |
$26K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
373 |
373 |
$20K |
| 67228 |
|
74 |
71 |
$18K |
| 76512 |
|
404 |
353 |
$12K |
| 92201 |
|
578 |
576 |
$7K |
| 92202 |
|
126 |
126 |
$1K |